3D Investment Partners has taken its multi-year campaign against Toho HD executives into full public confrontation, deploying a white paper, manga-format shareholder letters, and a dedicated campaign website — all timed immediately before the company's 78th annual general meeting.1
Toho HD's board installed a poison pill defense without a shareholder vote.1 That move, widely criticized by governance advocates, hands 3D a procedural argument: the board is acting to entrench itself rather than serve shareholders.
Bid-rigging allegations against Toho HD executives have also been surfaced by the activist fund as supporting evidence in its case for board change.1
The manga-format communications are notable. Japan's retail shareholder base responds to accessible, visual formats. 3D is not just lobbying institutional investors — it is building a broader coalition ahead of the vote.
The pattern is familiar. Activist campaigns that reached full public confrontation before Japan AGMs — including battles involving Toshiba and Seven & i — preceded material corporate restructuring.1 In each case, the public escalation phase signaled that back-channel negotiations had failed and that the activist believed it had enough votes to force change.
If 3D wins board seats at the 78th AGM, the likely next step is a formal strategic review, potentially leading to asset monetization or structural separation of Toho HD's business units.1
Japan's corporate governance reform era, driven by Tokyo Stock Exchange pressure on companies trading below book value, has shifted the environment. Institutional shareholders — both domestic and foreign — are more willing to vote against incumbent management than they were a decade ago. That structural shift benefits well-prepared activists.
The immediate question is vote arithmetic. Poison pills, white papers, and bid-rigging allegations are all pressure tactics. Whether 3D has assembled the coalition to actually win seats will be answered at the AGM.
